Geron (GERN) Retained Earnings (2010 - 2026)
Geron's (GERN) quarterly Retained Earnings came in at -$191000.0 in Q1 2026, down 162.83% year-on-year from $304000.0 in Q1 2025, and up 99.99% quarter-over-quarter from -$1.9 billion in Q4 2025.
Geron (GERN) Retained Earnings (2010 - 2026) Analysis & Trends
Geron has disclosed Retained Earnings across 17 years of filings, most recently posting -$191000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$191000.0, down 162.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$191000.0 (down 162.83% YoY), and the FY2025 annual result was -$1.9 billion, down 711150.19% from the prior year.
- Retained Earnings came in at -$191000.0 for Q1 2026 at Geron, up from -$1.9 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.0 million in Q3 2024 to a low of -$1.9 billion in Q4 2025.
- The 5-year median for Retained Earnings is -$1.3 billion (2022), against an average of -$841.5 million.
- Across the five-year window, Retained Earnings tumbled 44331966.67% in 2022 and soared 100.07% in 2024, its largest moves.
- Geron's Retained Earnings stood at -$1.4 billion in 2022, then soared by 100.01% to $185000.0 in 2023, then jumped by 41.08% to $261000.0 in 2024, then slumped by 711150.19% to -$1.9 billion in 2025, then soared by 99.99% to -$191000.0 in 2026.
- The last three Retained Earnings figures came in at -$191000.0 (Q1 2026), -$1.9 billion (Q4 2025), and -$1.8 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | -191,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -191,000.00 |
| Dec 31, 2025 | -1.86 Bn |
| Sep 30, 2025 | -1.83 Bn |
| Jun 30, 2025 | -1.81 Bn |
| Mar 31, 2025 | 304,000.00 |
| Dec 31, 2024 | 261,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | -537,000.00 |
| Mar 31, 2024 | -1.65 Bn |
| Dec 31, 2023 | 185,000.00 |
| Sep 30, 2023 | -1.55 Bn |
| Jun 30, 2023 | -1.50 Bn |
| Mar 31, 2023 | -160,000.00 |
| Dec 31, 2022 | -1.41 Bn |
| Sep 30, 2022 | -1.37 Bn |
| Jun 30, 2022 | -1.33 Bn |
| Mar 31, 2022 | -711,000.00 |
| Dec 31, 2021 | -173,000.00 |
| Sep 30, 2021 | -1.24 Bn |
| Jun 30, 2021 | 3,000.00 |